[HTML][HTML] Cross-country comparison of case fatality rates of COVID-19/SARS-COV-2

MA Khafaie, F Rahim - Osong public health and research …, 2020 - ncbi.nlm.nih.gov
… analysis was performed on the ongoing coronavirus disease 2019 (COVID-19) pandemic. …
the CFR of the COVID-19 pandemic seems to be less than Bird flu, Ebola, SARS, and MERS, …

[HTML][HTML] Recurrence of positive SARSCoV‐2 in patients recovered from COVID19

VT Hoang, TL Dao, P Gautret - Journal of medical virology, 2020 - ncbi.nlm.nih.gov
Dear Editor, In December 2019, an outbreak of respiratory infectious disease (COVID19)
due to a novel coronavirus (at the time officially named SARSCoV‐2) emerged in the city of …

[HTML][HTML] Viable SARS-CoV-2 in various specimens from COVID-19 patients

HW Jeong, SM Kim, HS Kim, YI Kim, JH Kim… - Clinical Microbiology …, 2020 - Elsevier
SARS-CoV-2 can be shed through various clinical specimens, such as saliva, stool and urine,
of COVID-19 … from COVID-19 patients using cell culture and an animal model. We detected …

Role of COVID-19 vaccines in SARS-CoV-2 variants

Z Zhou, Y Zhu, M Chu - Frontiers in immunology, 2022 - frontiersin.org
… of mutations of SARS-CoV-2 variants, the different approaches used in the development
of COVID-19 vaccines, and COVID-19 vaccine effectiveness against SARS-CoV-2 variants. …

Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications

IP Trougakos, K Stamatelopoulos, E Terpos… - Journal of Biomedical …, 2021 - Springer
… Likewise, extensive lung infection by SARS-CoV-2 in COVID-19, triggers capillary leakage
… examination of patients with COVID-19 revealed the existence of SARS-CoV-2 in multiple (…

SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma

E Andreano, G Piccini, D Licastro… - Proceedings of the …, 2021 - National Acad Sciences
coronavirus 2 (SARS-CoV-2) in the immune population, we coincupi bated the authentic
virus with a highly neutralizing plasma from a COVID-19 … changes suggests that SARS-CoV-2 …

Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19

BK Kumar, KVGC Sekhar, S Kunjiappan, J Jamalis… - Bioorganic …, 2020 - Elsevier
… like SARS, MERS, and Ebola. This review presents a critical analysis of druggable targets
SARS CoV-2, new drug discovery, development, and treatment opportunities for COVID-19. …

[HTML][HTML] An overview of COVID-19

Y Shi, G Wang, X Cai, J Deng, L Zheng… - Journal of Zhejiang …, 2020 - ncbi.nlm.nih.gov
… from infection with SARS-CoV-2 as coronavirus disease 2019 (COVID-19). COVID-19
represents a … Human monoclonal antibody combination against SARS coronavirus: synergy and …

[HTML][HTML] The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic

SP Otto, T Day, J Arino, C Colijn, J Dushoff, M Li… - Current Biology, 2021 - cell.com
… One year into the global COVID-19 pandemic, the focus of attention has shifted to the
emergence and spread of SARS-CoV-2 variants of concern (VOCs). After nearly a year of the …

SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes

CI Wu, PG Postema, E Arbelo, ER Behr, CR Bezzina… - Heart rhythm, 2020 - Elsevier
… the setting of the COVID-19 pandemic may … COVID-19–related issues such as fever, stress,
electrolyte disturbances, and use of antiviral drugs. Here, we describe the potential COVID-19